• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.

作者信息

Davidson Bruce L, Levi Marcel M

机构信息

Washington State University Floyd College of Medicine, Everett.

Amsterdam University Medical Centers, Amsterdam, the Netherlands.

出版信息

JAMA. 2023 Aug 1;330(5):471-472. doi: 10.1001/jama.2023.9535.

DOI:10.1001/jama.2023.9535
PMID:37526726
Abstract
摘要

相似文献

1
Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.治疗剂量肝素对因 COVID-19 住院患者的治疗效果
JAMA. 2023 Aug 1;330(5):471-472. doi: 10.1001/jama.2023.9535.
2
Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.治疗剂量肝素对因 COVID-19 住院患者的治疗效果——回复
JAMA. 2023 Aug 1;330(5):472-473. doi: 10.1001/jama.2023.9538.
3
Anticoagulation for COVID-19 Patients: A Bird's-Eye View.COVID-19 患者的抗凝治疗：鸟瞰。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211039288. doi: 10.1177/10760296211039288.
4
Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.COVID-19 诊断后住院和非住院患者的血栓并发症发生率。
Br J Haematol. 2021 Aug;194(3):542-546. doi: 10.1111/bjh.17522. Epub 2021 May 24.
5
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病：治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验)：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
6
Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.3型血管性血友病合并重症新型冠状病毒肺炎感染患者的一级血栓预防
Haemophilia. 2021 Jul;27(4):e517-e519. doi: 10.1111/hae.14252. Epub 2021 Jan 11.
7
Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY study.依诺肝素与未分级肝素预防心力衰竭住院患者静脉血栓栓塞事件的比较：随机对照 CERTIFY 研究的亚组分析。
Am Heart J. 2011 Feb;161(2):322-8. doi: 10.1016/j.ahj.2010.10.005.
8
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.COVID-19中的静脉血栓栓塞性疾病：病理生理学、治疗与预防
Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372.
9
Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.中低收入国家 COVID-19 住院患者抗凝和静脉血栓疾病管理的实用建议。
Am J Trop Med Hyg. 2021 Jan 11;104(3_Suppl):99-109. doi: 10.4269/ajtmh.20-1305.
10
Anticoagulation in hospitalized patients with COVID-19.COVID-19 住院患者的抗凝治疗。
Blood. 2022 Aug 25;140(8):809-814. doi: 10.1182/blood.2021014527.